Product
TT-00420 + Toripalimab
1 clinical trial
3 indications
Indication
Clear Cell Renal CarcinomaIndication
Bladder CancerClinical trial
An Open-Label, Multi-Cohort, Two-Stage, Phase Ib/II Clinical Study to Evaluate the Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Treating Advanced Urological TumorsStatus: Not yet recruiting, Estimated PCD: 2025-08-31